 |
| :>About Dementia :> Diagnosing :> Post Diagnosis :> Research :> Treatment |
|
 |
|
|
|
|
|
 View our Catalog
|
Get our E-Mail updates!
|
Take the
"Real Age Test"
Alzheimer's Treatment What research is being conducted to develop treatments?
Scientists are hard at work developing new and better treatments, including some that hold promise to halt or reverse the underlying processes of the disease - something none of the existing drugs for Alzheimer's are able to do. Scientists at the Fisher Center for Alzheimer's Research are leading this battle. 
|
Toll Free Support
1-800-540-3340
|
|
|
The mysteries of the brain...  |
|
Bea Gorman’s life story about living with familial Alzheimers.  |
|
 |
|
|
|
Ginkgo Proven to be an Effective Alzheimer's Treatment
Researchers investigated Alzheimer's treatment drugs to test their efficacy opposed to treatment with Ginkgo extract. Study results show that there is not a significant difference between receiving treatment using a drug or treatment using Ginkgo extract. Researchers concluded by noting that Ginkgo extract should be considered equally effective in the treatment of mild to moderate Alzheimer's dementia.
Researchers investigated Alzheimer's treatment drugs to test their efficacy opposed to treatment with Ginkgo extract. Study results show that there is not a significant difference between receiving treatment using a drug or treatment using Ginkgo extract. Researchers concluded by noting that Ginkgo extract should be considered equally effective in the treatment of mild to moderate Alzheimer's dementia.
The latest medication to be introduced, but still not on the PBS, is Donepezil (Aricept), an anti-cholinesterase inhibitor. Its main advantage is that it is over 1000 times a more potent inhibitor of acetyl cholinesterase, which is predominantly in the central nervous system, than Butyryl cholinesterase, which is mainly outside the CNS. As a result, Donepezil has very little in the way of side effects. Its other main advantages are that it is only a once daily dosage with a half life of about 70 hours. A steady state is reached in about three weeks. The standard dose is 5mgs daily and after one month, this can be increased to 10mgs. Research shows that doses in excess of 10mgs provide no advantage. Read More... An experimental treatment that could cost up to $10,000 a month has shown strong promise in treating Alzheimer's patients in a limited study. But patients who could manage to get this experimental treatment might be taking the medication from someone else who needs it for lymphocytic leukemia, myasthenia gravis or one of the other maladies that yield to the power of this precious substance. Read More...
Effective Alzheimer's Treatment with Minimal Side-EffectsThe benefits of taking acetylcholinesterase (AChE) inhibitors for Alzheimer's disease is well known and clinically proven. Huperzine A is a drug free AChE inhibitor. AChE inhibitors have the potential to delay the decline in cognitive and mental functions in Alzheimer patients. The multiple benefits Alzheimer patients experience as a result of including AChE inhibitors in their treatment program make them an excellent Alzheimer's treatment.
Scientists at Cardiff University have developed a potential treatment for Alzheimer's disease Researchers say they have created an antibody which could block the production of brain chemicals linked to the debilitating disease. Dr Emma Kidd, who led the research team, said the results of the tests were "highly encouraging". Namenda is different — the only product in its class. Namenda is effective when used alone or in combination with Aricept. Home * Diagnose * Research * Treatment * About Us * Newsletter * Store * Donate * News * Contact Us *
About Alzheimer' s * Post Diagnosis * Books and Videos * Bea Gorman * Events * Local Chapter *
Website Design:
WEBKING.US
